Jennifer Taubert
2019
In 2019, Jennifer Taubert earned a total compensation of $7.1M as EVP, Worldwide Chair Pharmaceuticals at Johnson & Johnson.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,237,000 |
|---|---|
| Non-Equity Incentive Plan | $1,179,065 |
| Option Awards | $1,200,004 |
| Salary | $796,154 |
| Stock Awards | $2,625,279 |
| Other | $59,798 |
| Total | $7,097,300 |
Taubert received $2.6M in stock awards, accounting for 37% of the total pay in 2019.
Taubert also received $1.2M of change in pension value and nonqualified deferred compensation earnings, $1.2M in non-equity incentive plan, $1.2M in option awards, $796.2K in salary and $59.8K in other compensation.
Rankings
In 2019, Jennifer Taubert's compensation ranked 1,345th out of 13,971 executives tracked by ExecPay. In other words, Taubert earned more than 90.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,345 out of 13,971 | 90th |
Division Manufacturing | 474 out of 5,692 | 92nd |
Major group Chemicals And Allied Products | 142 out of 2,189 | 94th |
Industry group Drugs | 113 out of 1,875 | 94th |
Industry Pharmaceutical Preparations | 84 out of 1,387 | 94th |
Source: SEC filing on March 10, 2021.
Taubert's colleagues
We found four more compensation records of executives who worked with Jennifer Taubert at Johnson & Johnson in 2019.